| 
           Income Taxes - Additional Information (Detail) (USD $) 
         | 
        12 Months Ended | ||
|---|---|---|---|
| 
           Dec. 31, 2014 
         | 
        
           Dec. 31, 2013 
         | 
        
           Dec. 31, 2012 
         | 
      |
| Income Tax Disclosure [Line Items] | |||
| Deferred Tax Assets, Valuation Allowance | $ 50,567,000us-gaap_DeferredTaxAssetsValuationAllowance | $ 41,142,000us-gaap_DeferredTaxAssetsValuationAllowance | |
| Effective Income Tax Rate Reconciliation Prior Year State Net Operating Loss True Up | 1.00%cndo_EffectiveIncometaxRateReconciliationPriorYearStateNetOperatingLossTrueUp | 5.00%cndo_EffectiveIncometaxRateReconciliationPriorYearStateNetOperatingLossTrueUp | |
| Effective Income Tax Rate Reconciliation Prior Year Federal Net Operating Loss True Up | 0.00%cndo_EffectiveIncomeTaxRateReconciliationPriorYearFederaNetOperatingLossTrueUp | ||
| Tax Payer Relief Act Research Credit Extension Period | 2 years | ||
| Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | 9,400,000us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount | ||
| Orphan Drug Tax Credit [Member] | |||
| Income Tax Disclosure [Line Items] | |||
| Tax Credit Carryforward, Amount | 
2,100,000us-gaap_TaxCreditCarryforwardAmount / us-gaap_CreditFacilityAxis = cndo_OrphanDrugTaxCreditMember  | 
        ||
| Research Tax Credit Carryforward [Member] | |||
| Income Tax Disclosure [Line Items] | |||
| Tax Credit Carryforward, Amount | 
3,800,000us-gaap_TaxCreditCarryforwardAmount / us-gaap_TaxCreditCarryforwardAxis = us-gaap_ResearchMember  | 
        ||
| Domestic Tax Authority [Member] | |||
| Income Tax Disclosure [Line Items] | |||
| Operating Loss Carryforwards | 
104,000,000us-gaap_OperatingLossCarryforwards / us-gaap_IncomeTaxAuthorityAxis = us-gaap_DomesticCountryMember  | 
        ||
| Domestic Tax Authority [Member] | Additional Paid-in Capital [Member] | |||
| Income Tax Disclosure [Line Items] | |||
| Operating Loss Carryforwards | 
1,800,000us-gaap_OperatingLossCarryforwards / us-gaap_IncomeTaxAuthorityAxis = us-gaap_DomesticCountryMember / us-gaap_StatementEquityComponentsAxis = us-gaap_AdditionalPaidInCapitalMember  | 
        ||
| State and Local Jurisdiction [Member] | |||
| Income Tax Disclosure [Line Items] | |||
| Operating Loss Carryforwards | 
50,700,000us-gaap_OperatingLossCarryforwards / us-gaap_IncomeTaxAuthorityAxis = us-gaap_StateAndLocalJurisdictionMember  | 
        ||
| State and Local Jurisdiction [Member] | Additional Paid-in Capital [Member] | |||
| Income Tax Disclosure [Line Items] | |||
| Operating Loss Carryforwards | 
$ 1,600,000us-gaap_OperatingLossCarryforwards / us-gaap_IncomeTaxAuthorityAxis = us-gaap_StateAndLocalJurisdictionMember / us-gaap_StatementEquityComponentsAxis = us-gaap_AdditionalPaidInCapitalMember  | 
        ||
| X | ||||||||||
| 
             
- Definition 
          Effective Income Tax Rate Reconciliation Prior Year Federal Net Operating Loss True Up No definition available. 
  | 
        
| X | ||||||||||
| 
             
- Definition 
          Effective income tax rate reconciliation prior year state net operating loss true up. No definition available. 
  | 
        
| X | ||||||||||
| 
             
- Details 
          
  | 
        
| X | ||||||||||
| 
             
- Definition 
          Tax payer relief act research credit extension period. No definition available. 
  | 
        
| X | ||||||||||
| 
             
- Definition 
          Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/presentationRef 
  | 
        
| X | ||||||||||
| 
             
- Definition 
          Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://www.xbrl.org/2003/role/presentationRef 
  | 
        
| X | ||||||||||
| 
             
- Definition 
          The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://www.xbrl.org/2003/role/presentationRef 
  | 
        
| X | ||||||||||
| 
             
- Definition 
          Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. Reference 1: http://www.xbrl.org/2003/role/presentationRef 
  | 
        
| X | ||||||||||
| 
             
- Details 
          
  | 
        
| X | ||||||||||
| 
             
- Details 
          
  | 
        
| X | ||||||||||
| 
             
- Details 
          
  | 
        
| X | ||||||||||
| 
             
- Details 
          
  |